---
title: Association Between Primary Care Supply and Population Morbidity and Mortality in France at the Territorial Level
nct_id: NCT07508423
overall_status: NOT_YET_RECRUITING
sponsor: MSPU de Pins-Justaret
study_type: OBSERVATIONAL
primary_condition: Mortality
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT07508423.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07508423"
ct_last_update_post_date: 2026-04-02
last_seen_at: "2026-05-12T06:57:31.214Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Association Between Primary Care Supply and Population Morbidity and Mortality in France at the Territorial Level

**NCT ID:** [NCT07508423](https://clinicaltrials.gov/study/NCT07508423)

## Key Facts

- **Status:** NOT_YET_RECRUITING
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 7000000
- **Lead Sponsor:** MSPU de Pins-Justaret
- **Conditions:** Mortality, Morbidity
- **Start Date:** 2026-06-01
- **Completion Date:** 2027-12-31
- **CT.gov Last Update:** 2026-04-02

## Brief Summary

The M-OSP study investigates the association between the density of primary care professionals, including general practitioners (GPs), and population-level health outcomes across 2,850 life-health territories in France. Evidence from several OECD countries suggests higher GP density may reduce mortality, particularly cause-specific mortality such as cardiovascular deaths, but uncertainties remain regarding generalizability and other health outcomes.

This cross-sectional epidemiological study uses aggregated, territory-level data from 2009-2022, including: mortality rates (age- and sex-standardized), hospitalizations (MCO), emergency department visits, and the distribution of primary care professionals and facilities (GPs, nurses, physiotherapists, dentists, midwives, gynecologists, pediatricians, psychiatrists, and community pharmacies).

## Eligibility

- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

All individuals affiliated with any French health insurance scheme and recorded in the Système National des Données de Santé (SNDS; French National Health Data System) through the Datamart de Consommation Inter-Régimes (DCIR; French national health insurance claims database) between January 1, 2009 and December 31, 2022
```

## Primary Outcomes

- **Mortality rate** _(time frame: 1 year)_ — Yearly mortality rate, standardized by age group and sex

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT07508423.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT07508423*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*